Skip to main content

Table 4 Prevalence of treatment for BL at 3 months and prevalence of histology showing NR and ≥ BL at 1 year in the BL subgroup divided by severity of tubulitis and interstitial inflammation

From: Effects of antirejection therapies for early subclinical acute rejection in renal transplant protocol biopsies

 

Treatment at 3 months

1 year

p

NR

 ≥ BL

Tubulitis (t score) at 3 months

 t1 (n = 69)

27 (39.1)

34 (49.3)

35 (50.7)

0.385

 t ≥ 2 (n = 14)

6 (42.9)

9 (64.3)

5 (35.7)

 

Interstitial inflammation (i score) at 3 months

 i0 (n = 20)

4 (20.0)

11 (55.0)

9 (45.0)

0.801

 i ≥ 1 (n = 63)

29 (46.0)

32 (50.8)

31 (49.2)

 
  1. Data are presented as n (%)
  2. NR normal findings, BL borderline changes